1

Exhibit 24



                              POWER OF ATTORNEY


        We, the undersigned directors of Duramed Pharmaceuticals, Inc. (the 
"Company") hereby appoint E. Thomas Arington and Timothy J. Holt or either of
them, with full power of substitution, our true and lawful attorneys and
agents, to do any and all acts and things in our names and on our behalf as
directors of the Company which is said attorneys and agents, or either of them,
may deem necessary or advisable to enable the Company to comply with the
securities Exchange Act of 1934, as amended, and any rules, regulations or
requirements of the Securities and Exchange Commission, in connection with the
filing of the Company's Annual Report on Form 10-K for the fiscal year ended
December 31, 1996 including, without limitation, signing for us, or any of us,
in our names as directors of the Company, such Form 10-K and any and all
amendments thereto, and we hereby ratify and confirm all that said attorney and
agents, or either of them, shall do or cause to be done by virtue hereof.

        Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, and the rules and regulations thereunder, this Power of Attorney has
been signed below by the following persons in the capacities indicated as of
the 27th day of March, 1997.



/s/ E. Thomas Arington                 Chairman of the Board
- ------------------------------
E. Thomas Arington


/s/ George W. Baughman                 Director
- ------------------------------
George W. Baughman


/s/ Derek G. Layton                    Director
- ------------------------------
Derek G. Layton


/s/ Stanley L. Morgan                  Director
- ------------------------------
Stanley L. Morgan


/s/ S. Sundararaman                    Director
- ------------------------------
S. Sundararaman